Brief: Hamilton Thorne announces the acquisition of Embryotech Laboratories
Sept 16 (Reuters) - Hamilton Thorne Ltd HTL.V
* Hamilton Thorne announces the acquisition of Embryotech
Laboratories
* Says transaction is expected to add over US$5 million of
revenue and more than us$1.5 million to EBITDA in calendar year
2017
* Expected to increase 2017 EBITDA by over 100%
* Total consideration of approximately us$7.25 million
* Estimates this transaction will be accretive to earnings
in 2016
Source text for Eikon: ID:nMKW8kVxla
Further company coverage: HTL.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Hamilton Thorne
See all newsBrief: Hamilton Thorne Announces Agreement To Be Acquired By Astorg
Brief: Hamilton Thorne Appoints Dr. Ekaterina (Kate) Torchilin As President And CEO
Brief: Hamilton Thorne Reports Record Revenue For The Quarter Ended March 31, 2023
Brief: Hamilton Thorne Posts Qtrly Diluted EPS $0.01
Brief: Hamilton Thorne Announces Record Revenue And Adjusted EBITDA For Q4 And Year Ended Dec 31 2022